Insider Buying: SVP Strategy & Compliance James Sullivan Acquires 9,000 Shares of BIO-key International Inc
Author's Avatar GuruFocus Research 14 hours ago Article's Main Image BKYI ?0.7% On September 11, 2023, James Sullivan, the Senior Vice President of Strategy & Compliance at BIO-key International Inc (BKYI, Financial), purchased 9,000 shares of the company. This move is significant as it indicates the insider's confidence in the company's future prospects.
BIO-key International Inc is a leading provider of biometric identity and access management solutions. The company's innovative software and hardware solutions deliver strong, convenient security, and user-friendly functionality, enabling its customers to enhance productivity and reduce costs.
Over the past year, the insider has purchased a total of 17,618 shares and has not sold any shares. This trend suggests a strong belief in the company's potential for growth and profitability.
1702113373530882048.png The insider transaction history for BIO-key International Inc shows a total of 5 insider buys over the past year, with no insider sells. This trend indicates a positive sentiment among the company's insiders, which could be a bullish signal for investors.
On the day of the insider's recent buy, shares of BIO-key International Inc were trading at $0.53, giving the company a market cap of $4.746 million.
With a price of $0.53 and a GuruFocus Value of $3.02, BIO-key International Inc has a price-to-GF-Value ratio of 0.18. This suggests that the stock is a possible value trap, and investors should think twice before investing.
1702113390006108160.png The GF Value is an intrinsic value estimate developed by GuruFocus. It is calculated based on historical multiples (price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow) that the stock has traded at, a GuruFocus adjustment factor based on the company’s past returns and growth, and future estimates of business performance from Morningstar analysts.
In conclusion, the insider's recent purchase of BIO-key International Inc shares could be a positive signal for the company's future prospects. However, given the stock's current price-to-GF-Value ratio, investors should exercise caution and conduct thorough research before making an investment decision
BIO-key International (NASDAQ:BKYI) Share Price Passes Below 50 Day Moving Average of $0.66 Defense World StaffSep 12th, 2023 BIO-key International logoBIO-key International, Inc. (NASDAQ:BKYI – Get Free Report)’s share price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.66 and traded as low as $0.51. BIO-key International shares last traded at $0.53, with a volume of 26,813 shares changing hands.
BIO-key International Price Performance
The company has a current ratio of 1.36, a quick ratio of 0.66 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $4.89 million, a P/E ratio of -0.47 and a beta of 1.05. The firm has a fifty day moving average of $0.66 and a 200 day moving average of $0.72.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Monday, August 14th. The technology company reported ($0.16) earnings per share for the quarter. The company had revenue of $1.93 million for the quarter. BIO-key International had a negative net margin of 117.65% and a negative return on equity of 122.43%.
About BIO-key International
(Get Free Report) BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.
WALL, N.J. and Herndon, Va., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), is proud to announce its acceptance into the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS Partners that provide software solutions that run on or integrate with AWS. Having joined the AWS Partner Network in June of 2022, acceptance to the Accelerate Program marks a significant milestone in BIO-key's journey to provide advanced biometric security solutions on AWS.
As a member of this program, BIO-key will access a wide range of resources and benefits, including technical enablement, go-to-market support, and co-selling opportunities, allowing the company to deliver enhanced security offerings to AWS customers, globally.
BIO-key's biometric authentication solutions offer unparalleled security and convenience, leveraging unique biometric identifiers such as fingerprints, faces, palm scans, and more. With support from AWS, BIO-key aims to make its cutting-edge biometric technology easily accessible to businesses of all sizes, from startups to enterprises, seeking to fortify their digital environments against ever-evolving cybersecurity threats.
"BIO-key is thrilled to be accepted into the AWS ISV Accelerate Program, which validates the strength of our biometric authentication solutions and our commitment to innovation in the field of cybersecurity," said Galen Rodgers, VP of Sales & Channel, BIO-key International. "Our work with AWS will help us to further enhance the security posture of organizations using AWS, providing a frictionless yet robust authentication experience for users."
As BIO-key works with AWS to continue expanding its reach and capabilities, both companies are committed to driving innovation and raising the bar for security solutions in the cloud computing landscape.